Amylyx Pharmaceuticals (AMLX) had the highest return between July 24, 2026 and August 24, 2026 by a mid-cap US stock, returning 116.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Amylyx Pharmaceuticals (AMLX) | 7/24/2026 - 8/24/2026 | 116.64% |
Heartflow, Inc Common Stock (HTFL) | 7/24/2026 - 8/24/2026 | 100.96% |
Abcellera Biologics (ABCL) | 7/24/2026 - 8/24/2026 | 87.13% |
NIQ Global Intelligence (NIQ) | 7/24/2026 - 8/24/2026 | 81.63% |
Appian (APPN) | 7/24/2026 - 8/24/2026 | 72.1% |
Wix (WIX) | 7/24/2026 - 8/24/2026 | 70.72% |
Caris Life Sciences, Inc Common Stock (CAI) | 7/24/2026 - 8/24/2026 | 66.01% |
Ringcentral (RNG) | 7/24/2026 - 8/24/2026 | 65.97% |
Hyperliquid Strategies Inc Common Stock (PURR) | 7/24/2026 - 8/24/2026 | 62.2% |
Strive (ASST) | 7/24/2026 - 8/24/2026 | 61.99% |
Figs (FIGS) | 7/24/2026 - 8/24/2026 | 61.64% |
Uipath (PATH) | 7/24/2026 - 8/24/2026 | 61.34% |
Amplitude (AMPL) | 7/24/2026 - 8/24/2026 | 59.98% |
Pulse Biosciences (PLSE) | 7/24/2026 - 8/24/2026 | 58.28% |
Aura Minerals Inc Common Shares (AUGO) | 7/24/2026 - 8/24/2026 | 58.17% |
Iovance Biotherapeutics (IOVA) | 7/24/2026 - 8/24/2026 | 57.12% |
Rumble (RUM) | 7/24/2026 - 8/24/2026 | 55.22% |
NovaGold Resources (NG) | 7/24/2026 - 8/24/2026 | 55.06% |
Blackbaud (BLKB) | 7/24/2026 - 8/24/2026 | 51.4% |
Intapp (INTA) | 7/24/2026 - 8/24/2026 | 51.11% |
DRDGOLD Limited ADR (DRD) | 7/24/2026 - 8/24/2026 | 49.23% |
Bausch Health Companies (BHC) | 7/24/2026 - 8/24/2026 | 49.11% |
Aveanna Healthcare (AVAH) | 7/24/2026 - 8/24/2026 | 48.27% |
B2Gold (BTG) | 7/24/2026 - 8/24/2026 | 48.19% |
Sibanye Gold Ltd ADR (SBSW) | 7/24/2026 - 8/24/2026 | 48.1% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.